MLC3F transgene expression in iv mutant mice reveals the importance of left-right signalling pathways for the acquisition of left and right atrial but not ventricular compartment identity
D. Franco et al., MLC3F transgene expression in iv mutant mice reveals the importance of left-right signalling pathways for the acquisition of left and right atrial but not ventricular compartment identity, DEV DYNAM, 221(2), 2001, pp. 206-215
Transcriptional differences between left and right cardiac chambers are rev
ealed by an nlacZ reporter transgene controlled by regulatory sequences of
the MLC3F gene, which is expressed in the left ventricle (LV), atrioventric
ular canal (AVC), and right atrium (RA), To examine the role of left-right
signalling in the acquisition of left and right chamber identity, we have i
nvestigated MLC3F transgene expression in iv mutant mice. iv/iv mice exhibi
t randomised direction of heart looping and an elevated frequency of associ
ated laterality defects, including atrial isomerism, At fetal stages, 3F-nl
acZ-2E transgene expression remains confined to the morphological LV, AVC,
and RA in L-loop hearts, although these appear on the opposite side of the
body. In cases of morphologically distinguishable right atrial appendage is
omerism, both atrial appendages show strong transgene expression. Conversel
y, specimens with morphological left atrial appendage isomerism show only w
eak expression in both atrial appendages. The earliest left-right atrial di
fferences in the expression of the 3F-nLacZ-2E transgene are observed at E8
.5. DiI labelling experiments confirmed that transcriptional regionalisatio
n of the 3F-nlacZ-2E transgene at this stage reflects future atrial chamber
identity, In some iv/iv embryos at E8.5, the asymmetry of 3F-nlacZ-2E expr
ession was lost, suggesting atrial isomerism at the transcriptional level p
rior to chamber formation. These data suggest that molecular specification
of left and right atrial but not ventricular chambers is dependent on left-
right axial cues. (C) 2001 Wiley-Liss, Inc.